Organization
CuraSen Therapeutics
3 clinical trials
Clinical trial
A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of CST-2032 and CST-107 on Cognition in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2023-12-01
Clinical trial
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Use of CST-103 Co-administered With CST-107 on Freezing of Gait in Subjects With Parkinson's DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 Co-administered With CST-107 on the Central Nervous System in Subjects With Neurodegenerative DisordersStatus: Active (not recruiting), Estimated PCD: 2022-07-04